The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
3-aminobenzamide promotes the reaction [Alitretinoin promotes the reaction [T0901317 results in increased expression of ABCA1 mRNA]]; 3-aminobenzamide promotes the reaction [Alitretinoin results in increased expression of ABCA1 mRNA]; Alitretinoin promotes the reaction [T0901317 results in increased expression of ABCA1 mRNA]; Alitretinoin promotes the reaction [T0901317 results in increased expression of ABCA1 protein]; T0901317 promotes the reaction [Alitretinoin results in increased expression of ABCA1 mRNA] [22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 protein; [25-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 protein; [Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 mRNA; [Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 protein; Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 mRNA]; Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 protein] [22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 mRNA; [22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 protein
Alitretinoin results in increased expression of ACTA2 mRNA 15-deoxyprostaglandin J2 inhibits the reaction [Alitretinoin results in increased expression of ACTA2 mRNA]; Alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of ACTA2 mRNA]
Alitretinoin results in decreased phosphorylation of AKT1 protein Alitretinoin results in increased phosphorylation of AKT1 protein [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of AKT1 protein
Alitretinoin results in increased expression of BAX; Alitretinoin results in increased expression of BAX protein seocalcitol inhibits the reaction [Alitretinoin results in increased expression of BAX protein]
Alitretinoin results in decreased expression of BCL2; Alitretinoin results in decreased expression of BCL2 protein BCL2 protein results in decreased susceptibility to Alitretinoin
[Calcitriol co-treated with Alitretinoin] results in increased expression of BGLAP mRNA; [Calcitriol co-treated with Alitretinoin] results in increased secretion of BGLAP protein; [KH 1060 co-treated with Alitretinoin] results in increased expression of BGLAP mRNA; [KH 1060 co-treated with Alitretinoin] results in increased secretion of BGLAP protein; Alitretinoin promotes the reaction [Calcitriol results in increased expression of BGLAP mRNA]; Alitretinoin promotes the reaction [Calcitriol results in increased secretion of BGLAP protein]; Alitretinoin promotes the reaction [KH 1060 results in increased expression of BGLAP mRNA]; Alitretinoin promotes the reaction [KH 1060 results in increased secretion of BGLAP protein]; Alitretinoin promotes the reaction [RXRB protein binds to BGLAP gene]; Alitretinoin promotes the reaction [VDR protein binds to BGLAP gene] Alitretinoin results in decreased expression of BGLAP mRNA
Alitretinoin results in increased expression of CASP3; Alitretinoin results in increased expression of CASP3 protein [T0901317 co-treated with Alitretinoin] promotes the reaction [Palmitic Acid results in increased activity of CASP3 protein]
Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased expression of CCNA2 protein]
Alitretinoin results in decreased expression of CCR2 mRNA; Alitretinoin results in decreased expression of CCR2 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Alitretinoin results in decreased expression of CCR2 mRNA]
Alitretinoin results in decreased expression of CD36 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Alitretinoin results in decreased expression of CD36 protein]; [Alitretinoin co-treated with Rosiglitazone] results in increased expression of CD36 protein; HX 630 inhibits the reaction [Alitretinoin results in decreased expression of CD36 protein]
Alitretinoin results in increased expression of CD38 mRNA Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CD38 mRNA]; periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CD38 mRNA]]
Alitretinoin results in decreased expression of CD80 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Alitretinoin results in decreased expression of CD80 protein]; [Alitretinoin co-treated with Rosiglitazone] results in decreased expression of CD80 protein; HX 630 inhibits the reaction [Alitretinoin results in decreased expression of CD80 protein]
Alitretinoin results in increased expression of CD86 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Alitretinoin results in increased expression of CD86 protein]; [Alitretinoin co-treated with Rosiglitazone] results in increased expression of CD86 protein; HX 630 inhibits the reaction [Alitretinoin results in increased expression of CD86 protein]
Alitretinoin results in increased stability of CDKN1B protein Alitretinoin results in increased expression of CDKN1B protein Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein]; seocalcitol inhibits the reaction [Alitretinoin results in increased expression of CDKN1B protein]
15-deoxyprostaglandin J2 inhibits the reaction [Alitretinoin results in increased expression of CNN1 mRNA]; Alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of CNN1 mRNA]
Alitretinoin results in increased expression of CRABP2 mRNA Alitretinoin analog results in increased expression of CRABP2 mRNA; Alitretinoin results in increased expression of CRABP2 mRNA
Alitretinoin promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA] [Alitretinoin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein; Alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]]; Alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA] Alitretinoin results in increased expression of CYP19A1 mRNA Alitretinoin results in decreased expression of CYP19A1 mRNA
Alitretinoin inhibits the reaction [CYP26C1 protein binds to and results in increased metabolism of Tretinoin]; CYP26C1 protein binds to and results in increased metabolism of Alitretinoin; Ketoconazole inhibits the reaction [CYP26C1 protein results in increased metabolism of Alitretinoin] CYP26C1 results in increased metabolism of Alitretinoin Alitretinoin results in increased expression of CYP26C1 mRNA
Alitretinoin results in increased expression of CYP27A1 mRNA Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CYP27A1 mRNA]; periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CYP27A1 mRNA]] Alitretinoin results in decreased expression of CYP27A1 mRNA
Alitretinoin results in increased activity of CYP3A4 protein 1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; Alitretinoin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; Alitretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]
[Arsenicals co-treated with Alitretinoin] results in increased expression of DNMT1 mRNA; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT1 mRNA
[Arsenicals co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in increased expression of DNMT3A mRNA
Alitretinoin inhibits the reaction [Paclitaxel results in increased expression of ESR1 mRNA] Alitretinoin results in decreased expression of ESR1 mRNA Melatonin promotes the reaction [Alitretinoin results in decreased expression of ESR1 mRNA]
Alitretinoin results in increased expression of FHL1 mRNA 15-deoxyprostaglandin J2 inhibits the reaction [Alitretinoin results in increased expression of FHL1 mRNA]; Alitretinoin promotes the reaction [25-hydroxycholesterol results in increased expression of FHL1 mRNA]
Alitretinoin results in increased expression of FN1 mRNA Alitretinoin results in decreased expression of FN1 mRNA; Alitretinoin results in decreased expression of FN1 protein
Alitretinoin results in increased expression of GH1 mRNA Alitretinoin promotes the reaction [Triiodothyronine results in increased expression of GH1 mRNA]; Pentetic Acid promotes the reaction [Alitretinoin promotes the reaction [Triiodothyronine results in increased expression of GH1 mRNA]]; Pentetic Acid promotes the reaction [Alitretinoin results in increased expression of GH1 mRNA]; Pentetic Acid promotes the reaction [Triiodothyronine promotes the reaction [Alitretinoin results in increased expression of GH1 mRNA]]; Triiodothyronine promotes the reaction [Alitretinoin results in increased expression of GH1 mRNA]; Zinc inhibits the reaction [Pentetic Acid promotes the reaction [Alitretinoin promotes the reaction [Triiodothyronine results in increased expression of GH1 mRNA]]]; Zinc inhibits the reaction [Pentetic Acid promotes the reaction [Alitretinoin results in increased expression of GH1 mRNA]]; Zinc inhibits the reaction [Pentetic Acid promotes the reaction [Triiodothyronine promotes the reaction [Alitretinoin results in increased expression of GH1 mRNA]]]
[9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter]; [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased expression of GSTA2 mRNA; [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased expression of GSTA2 protein; [Pioglitazone co-treated with Alitretinoin] results in increased expression of GSTA2 protein; [Rosiglitazone co-treated with Alitretinoin] results in increased expression of GSTA2 protein; [Troglitazone co-treated with Alitretinoin] results in increased expression of GSTA2 protein Alitretinoin results in increased expression of GSTA2 protein
[Alitretinoin co-treated with Dimethyl Sulfoxide] promotes the reaction [H3-4 protein modified form binds to TGM2 gene]; Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased acetylation of H3-4 protein]
Alitretinoin results in decreased expression of HGF mRNA Alitretinoin results in increased secretion of HGF protein Alitretinoin results in increased expression of HGF mRNA Alitretinoin results in decreased secretion of HGF protein
[22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG results in increased expression of STAT1 mRNA]; Alitretinoin inhibits the reaction [IFNG results in increased expression of NR1H3 mRNA]; Alitretinoin inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein] Alitretinoin results in decreased expression of IFNG mRNA; Alitretinoin results in decreased expression of IFNG protein Alitretinoin results in decreased secretion of IFNG protein
[Alitretinoin binds to RARB protein] which binds to IGFBP3 promoter Alitretinoin results in increased expression of IGFBP3 mRNA; Alitretinoin results in increased expression of IGFBP3 protein
Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; Alitretinoin results in decreased expression of [IL12A protein binds to IL12B protein]
Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; Alitretinoin results in decreased expression of [IL12A protein binds to IL12B protein] Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]
[Fenofibrate co-treated with Alitretinoin] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]; Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] Alitretinoin results in increased expression of IL1B mRNA
Alitretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein] Alitretinoin results in decreased expression of IL2 mRNA; Alitretinoin results in decreased expression of IL2 protein
Alitretinoin results in increased expression of IL4 mRNA; Alitretinoin results in increased expression of IL4 protein Alitretinoin results in increased secretion of IL4 protein IL4 protein promotes the reaction [Alitretinoin results in increased secretion of IL4 protein]
Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein]; Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased expression of CCNA2 protein]; Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased phosphorylation of RB1 protein] [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with Alitretinoin] results in increased expression of SLC27A1 mRNA; [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with Alitretinoin] results in increased uptake of Oleic Acid; [Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased susceptibility to Alitretinoin; Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with Alitretinoin] results in increased expression of SLC27A1 mRNA]
Alitretinoin results in increased expression of IRF1; Alitretinoin results in increased expression of IRF1 mRNA; Alitretinoin results in increased expression of IRF1 protein
Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of ITGAM protein]; Vitamin D promotes the reaction [Alitretinoin results in increased expression of ITGAM protein]
Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of ITGAX protein]; Vitamin D promotes the reaction [Alitretinoin results in increased expression of ITGAX protein]
[Alitretinoin co-treated with Tretinoin co-treated with Calcitriol] results in increased expression of JUN protein; Alitretinoin inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of KLF6 protein; RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of KLF6 protein]
[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of LPL mRNA; [Alitretinoin co-treated with T0901317] results in increased expression of LPL mRNA Alitretinoin results in increased expression of LPL mRNA
Alitretinoin results in increased expression of MAP2 protein Alitretinoin results in decreased expression of MAP2 mRNA; Alitretinoin results in decreased expression of MAP2 protein
Alitretinoin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of MAPK1 protein
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of MAPK3 protein Alitretinoin results in decreased phosphorylation of and results in decreased activity of MAPK3 protein
[Arsenicals co-treated with Alitretinoin] results in decreased expression of MIR152 mRNA; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in decreased expression of MIR152 mRNA
[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Alitretinoin] promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]; [Alitretinoin co-treated with NCOA1 protein] results in increased activity of RXRB protein; Alitretinoin promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]
[9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased activity of NFE2L2 protein Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]
[Alitretinoin co-treated with 22-hydroxycholesterol] affects the localization of NR1H3 protein; Alitretinoin inhibits the reaction [IFNG results in increased expression of NR1H3 mRNA]
1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; [1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Alitretinoin] promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]; Alitretinoin binds to and results in increased activity of NR1I3 protein alternative form; Alitretinoin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; Alitretinoin promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]; Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter] Alitretinoin results in increased activity of [RXRA protein binds to NR1I3 protein]
Alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]]; Alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA] Alitretinoin results in decreased expression of NR5A2 mRNA
Alitretinoin results in increased expression of PCK1 mRNA [Tretinoin co-treated with Alitretinoin] affects the reaction [Vitamin A affects the expression of PCK1 mRNA]
Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein]; Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased expression of CCNA2 protein]; Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased phosphorylation of RB1 protein]
Alitretinoin results in increased activity of PPARG protein [Pioglitazone co-treated with Alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]; PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA] benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Alitretinoin results in increased activity of PPARG protein]; MG 262 promotes the reaction [Alitretinoin results in increased activity of PPARG protein] [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter]; Alitretinoin binds to and results in increased activity of PPARG protein
Alitretinoin results in increased expression of PPARGC1A mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA]; PPARG protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA]; RXRA protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA]
Alitretinoin results in decreased expression of PTHLH mRNA Alitretinoin promotes the reaction [Calcitriol results in decreased expression of PTHLH mRNA]
Alitretinoin results in increased expression of RARA protein Alitretinoin binds to and results in increased activity of RARA protein; Alitretinoin promotes the reaction [RARA protein binds to PRAME protein]; RARA protein promotes the reaction [Alitretinoin results in increased expression of ABCC6 mRNA] Alitretinoin results in increased expression of RARA mRNA Alitretinoin results in decreased expression of RARA protein [Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [Alitretinoin results in increased activity of RARA protein]; CAMK4 protein promotes the reaction [Alitretinoin results in increased activity of RARA protein]; Dizocilpine Maleate inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [Alitretinoin results in increased activity of RARA protein]]; KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [Alitretinoin results in increased activity of RARA protein]]; Okadaic Acid promotes the reaction [Alitretinoin results in increased activity of RARA protein]; STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] promotes the reaction [Alitretinoin results in increased activity of RARA protein]]; trichostatin A promotes the reaction [Alitretinoin results in increased activity of RARA protein]
[Alitretinoin binds to RARB protein] which binds to IGFBP3 promoter Alitretinoin results in increased expression of RARB mRNA; Alitretinoin results in increased expression of RARB protein [Arsenicals co-treated with Alitretinoin] affects the expression of RARB mRNA; [Arsenicals co-treated with Alitretinoin] results in decreased expression of RARB protein; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in decreased expression of RARB mRNA; [Arsenicals co-treated with Poly I-C co-treated with Alitretinoin] results in decreased expression of RARB protein; Alitretinoin binds to and results in increased activity of RARB protein [Alitretinoin co-treated with RXRA protein] results in increased expression of RARB mRNA; sodium arsenite inhibits the reaction [[Alitretinoin co-treated with RXRA protein] results in increased expression of RARB mRNA] Alitretinoin binds to [RXRA protein binds to RARB protein]
Alitretinoin results in decreased expression of RARG protein RARG gene mutant form results in decreased susceptibility to Alitretinoin Alitretinoin binds to and results in increased activity of RARG protein Alitretinoin results in increased activity of RARG protein Alitretinoin results in increased expression of RARG mRNA
Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in increased phosphorylation of RB1 protein] Alitretinoin results in decreased phosphorylation of RB1 protein
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein; RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased expression of TGFB1 mRNA]; RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of KLF6 protein]
[Alitretinoin co-treated with RXRA protein] results in increased expression of RARB mRNA; Alitretinoin binds to and results in increased activity of RXRA protein; Alitretinoin inhibits the reaction [TGIF1 protein binds to RXRA protein]; Alitretinoin inhibits the reaction [TGIF1 protein results in increased activity of RXRA protein]; Alitretinoin results in increased activity of [RXRA protein binds to NR1I3 protein]; Alitretinoin results in increased activity of [RXRA protein binds to RXRA protein]; ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate inhibits the reaction [Alitretinoin results in increased activity of [RXRA protein binds to RXRA protein]]; RXRA protein promotes the reaction [Alitretinoin results in increased expression of PPARGC1A mRNA]; sodium arsenite inhibits the reaction [[Alitretinoin co-treated with RXRA protein] results in increased expression of RARB mRNA] Alitretinoin results in increased localization of RXRA protein Alitretinoin results in increased expression of RXRA mRNA Alitretinoin affects the localization of RXRA protein 1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; [1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Alitretinoin] promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]; [Alitretinoin binds to and results in increased activity of RXRA protein] which results in increased expression of CYP19A1 protein; [Alitretinoin co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the localization of RXRA protein; [Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein]; [Alitretinoin co-treated with RXRA protein] results in increased expression of PSG5 mRNA; [Alitretinoin results in increased activity of RXRA protein] which binds to PSG5 promoter; [pirinixic acid co-treated with Alitretinoin co-treated with PPARA protein co-treated with RXRA protein] results in decreased expression of UGDH mRNA; Alitretinoin analog binds to and results in increased activity of RXRA protein; Alitretinoin binds to and affects the activity of RXRA protein; Alitretinoin binds to and results in increased activity of RXRA protein; Alitretinoin inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]; Alitretinoin inhibits the reaction [triphenyltin hydroxide binds to RXRA protein]; Alitretinoin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]]; Alitretinoin promotes the reaction [[NR1I3 protein binds to RXRA protein] which binds to NCOA1 protein]; Alitretinoin promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which binds to CYP3A4 promoter]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Alitretinoin results in increased degradation of RXRA protein]; Flurbiprofen inhibits the reaction [Alitretinoin binds to RXRA protein]; RXRA promotes the reaction [Alitretinoin results in increased expression of APOA2 mRNA]; RXRA protein affects the reaction [Alitretinoin results in increased expression of CYP2B6 mRNA]; tributyltin inhibits the reaction [Alitretinoin binds to RXRA protein]; triphenyl bismuth inhibits the reaction [Alitretinoin binds to RXRA protein]; triphenylarsine inhibits the reaction [Alitretinoin binds to RXRA protein]; triphenyltin chloride inhibits the reaction [Alitretinoin binds to RXRA protein]; triphenyltin hydroxide inhibits the reaction [Alitretinoin binds to RXRA protein] Alitretinoin results in decreased expression of RXRA protein [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] Alitretinoin binds to RXRA protein; RXRA protein binds to Alitretinoin Alitretinoin results in increased expression of RXRA protein Alitretinoin binds to [RXRA protein binds to RARB protein] Alitretinoin results in increased ubiquitination of RXRA protein
Alitretinoin results in increased degradation of RXRB protein 2,4,6-trichlorophenol inhibits the reaction [Alitretinoin binds to and results in increased activity of RXRB protein]; [Alitretinoin co-treated with NCOA1 protein] results in increased activity of RXRB protein; Alitretinoin binds to and affects the activity of RXRB protein; Alitretinoin promotes the reaction [RXRB protein binds to BGLAP gene]; bisphenol A analog inhibits the reaction [Alitretinoin binds to and results in increased activity of RXRB protein]; bisphenol A inhibits the reaction [Alitretinoin binds to and results in increased activity of RXRB protein]; tetrachlorodian inhibits the reaction [Alitretinoin binds to and results in increased activity of RXRB protein] Alitretinoin results in increased expression of RXRB protein Alitretinoin results in increased activity of RXRB protein Alitretinoin binds to RXRB protein
Alitretinoin results in increased expression of RXRG mRNA Alitretinoin results in decreased expression of RXRG mRNA Alitretinoin binds to RXRG protein Alitretinoin affects the activity of RXRG protein Alitretinoin binds to and affects the activity of RXRG protein
Alitretinoin promotes the reaction [Fenofibrate results in decreased expression of SEMA6B mRNA]; Alitretinoin promotes the reaction [Fenofibrate results in decreased expression of SEMA6B protein]; Alitretinoin promotes the reaction [Troglitazone results in decreased expression of SEMA6B mRNA]; Alitretinoin promotes the reaction [Troglitazone results in decreased expression of SEMA6B protein]
[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with Alitretinoin] results in increased expression of SLC27A1 mRNA; Dactinomycin inhibits the reaction [[[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] co-treated with Alitretinoin] results in increased expression of SLC27A1 mRNA] Dactinomycin inhibits the reaction [Alitretinoin results in increased expression of SLC27A1 mRNA]
Alitretinoin results in decreased expression of SPP1 mRNA Alitretinoin results in decreased expression of SPP1 mRNA; Alitretinoin results in decreased expression of SPP1 protein Alitretinoin results in increased expression of SPP1 mRNA
[22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG results in increased expression of STAT1 mRNA]; Alitretinoin inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein]; Alitretinoin results in increased phosphorylation of and results in increased activity of STAT1 protein
Alitretinoin results in increased phosphorylation of TBC1D4 protein Oligomycins promotes the reaction [Alitretinoin results in increased phosphorylation of TBC1D4 protein]
Alitretinoin inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 protein] Alitretinoin results in decreased expression of TGFB1 mRNA Alitretinoin results in decreased activity of TGFB1 protein 15-deoxy-delta(12,14)-prostaglandin J2 promotes the reaction [Alitretinoin results in decreased expression of TGFB1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Alitretinoin co-treated with 15-deoxy-delta(12,14)-prostaglandin J2] results in decreased expression of TGFB1 mRNA]; bisphenol A diglycidyl ether inhibits the reaction [[Alitretinoin co-treated with 15-deoxy-delta(12,14)-prostaglandin J2] results in decreased expression of TGFB1 mRNA]; RPS6KB1 protein inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased expression of TGFB1 mRNA] Alitretinoin results in decreased susceptibility to TGFB1 protein
Alitretinoin results in increased expression of TGIF1 protein Alitretinoin inhibits the reaction [TGIF1 protein binds to RXRA protein]; Alitretinoin inhibits the reaction [TGIF1 protein results in increased activity of RXRA protein]
[Alitretinoin co-treated with Dimethyl Sulfoxide] promotes the reaction [H3-4 protein modified form binds to TGM2 gene]; [Alitretinoin co-treated with Dimethyl Sulfoxide] promotes the reaction [H4C16 protein modified form binds to TGM2 gene]; Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of TGM2 mRNA]; Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of TGM2 protein]; periodate-oxidized adenosine inhibits the reaction [Alitretinoin results in increased expression of TGM2 mRNA]; periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of TGM2 mRNA]]; Vitamin D promotes the reaction [Alitretinoin results in increased expression of TGM2 mRNA] Alitretinoin results in increased activity of TGM2 protein Alitretinoin results in increased expression of TGM2 mRNA; Alitretinoin results in increased expression of TGM2 protein
[Fenofibrate co-treated with Alitretinoin] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Alitretinoin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Alitretinoin inhibits the reaction [TNF protein results in increased expression of CYP4F11 mRNA]; Alitretinoin inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein] Alitretinoin results in decreased expression of TNF mRNA; Alitretinoin results in decreased expression of TNF protein
Alitretinoin results in increased expression of UCP1 mRNA 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Alitretinoin results in increased expression of UCP1 mRNA]; Glutathione inhibits the reaction [Alitretinoin results in increased expression of UCP1 mRNA]
[Alitretinoin co-treated with Calcitriol] results in increased stability of [RXRA protein binds to VDR protein]; Alitretinoin promotes the reaction [VDR protein binds to BGLAP gene] Alitretinoin results in increased degradation of VDR protein Alitretinoin affects the activity of VDR protein
Alitretinoin results in decreased expression of VIM mRNA; Alitretinoin results in decreased expression of VIM protein [Tretinoin co-treated with Alitretinoin] results in decreased expression of VIM mRNA; Tretinoin promotes the reaction [Alitretinoin results in decreased expression of VIM protein]
browse the term
